Document is current
Any future updates will be listed below
-
Authors
Ma, Ting Martin
Lamb, James M.
Casado, Maria
Wang, Xiaoyan
Basehart, T. Vincent
Yang, Yingli
Low, Daniel
Sheng, Ke
Agazaryan, Nzhde
Nickols, Nicholas G.
Cao, Minsong
Steinberg, Michael L.
Kishan, Amar U.
-
Funding
Funding for this research was provided by:
Prostate Cancer Foundation
American Society for Radiation Oncology
- License Information
-
More Information
Article History
Received: 29 September 2020
Accepted: 2 May 2021
First Online: 11 May 2021
Declarations
:
: The study is approved by the Institutional Review Board (IRB) of the University of California Los Angeles (UCLA IRB #20–000328). Subjects consent to participate after thorough discussion by signing of the IRB approved informed consent document. If any major amendments are made, subjects will be given the opportunity to re-consent after a full disclosure by the principal investigator and the clinical research coordinator.
: This manuscript does not include details, images, or videos relating to an individual person.
: The authors declare that they have no competing interests within the scope of the submitted work. Full disclosures include: AUK received honoraria from Varian Medical Systems, Inc. and ViewRay Inc., outside the scope of the submitted work. NN received research support from Janssen, Varian, and Bayer; stock options with GSI Inc. and ROAR; and consulting with GSI Inc., outside the scope of the submitted work. MC received speaker honorarium from ViewRay Inc. and Varian Medical System Inc., outside the scope of the submitted work. YY received speaker honorarium and consulting from Viewray inc., outside the scope of the submitted work.
